Organigram Global R&D Spending Growth & History (OGI)
Organigram Global's r&d spending was $10.9M for fiscal 2025.
View full Organigram Global company overviewOrganigram Global annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $10.9M | −$255,000 | −2.28% |
| 2024 | 2024-09-30 | $11.2M | −$2.0M | −15.16% |
| 2023 | 2023-09-30 | $13.2M | — | — |
| 2022 | 2022-08-31 | $6.0M | $2.3M | +63.57% |
| 2021 | 2021-08-31 | $3.6M | $2.4M | +187.23% |
| 2020 | 2020-08-31 | $1.3M | $860,000 | +210.27% |
| 2019 | 2019-08-31 | $409,000 | $409,000 | — |
| 2018 | 2018-08-31 | $0 | — | — |
Organigram Global quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $2.2M | −$548,000 | −19.83% |
| Q2 2026 | 2026-03-31 | $2.0M | −$637,000 | −23.93% |
| Q1 2026 | 2025-12-31 | $2.1M | — | — |
| Q4 2025 | 2025-09-30 | $3.2M | — | — |
| Q3 2025 | 2025-06-30 | $2.8M | — | — |
| Q2 2025 | 2025-03-31 | $2.7M | — | — |
Organigram Global r&d spending trends
Between the periods ended 2018-08-31 and 2025-09-30, Organigram Global's r&d spending increased from $0 to $10.9M, a change of $10.9M. The latest reported quarter, Q3 2026, shows $2.2M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Organigram Global source filings ↗